相关实验视频
Updated: Jun 5, 2025

08:25
Flow Cytometric Characterization of Murine B Cell Development
Published on: January 22, 2021
15.3K
免疫检查点在B细胞淋巴瘤:从基础研究到临床实践仍然是一个未解决的挑战
Sijia Li1, Yuanyuan Pan1, Ruyu Ye1
1Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, PR China.
International immunopharmacology
|December 14, 2024
概括
新的癌症免疫疗法针对CTLA-4,PD-1和LAG-3等免疫检查点. 虽然目前的抑制剂显示出前景,但探索像TIGIT和TIM-3这样的新目标为有效的淋巴瘤治疗提供了新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点 (CTLA-4,PD-1,LAG-3,TIM-3,TIGIT) 在瘤微环境中至关重要.
- 针对PD-1/PD-L1或CTLA-4的免疫检查点抑制剂 (ICI) 用于B细胞淋巴瘤.
- 目前ICI的长期收益有限,需要探索新的目标.
研究的目的:
- 审查ICI在T细胞活性中的抗瘤作用和功能.
- 讨论ICI与其他免疫疗法的结合方面的进展.
- 突出新兴的免疫检查点目标,如LAG-3,TIM-3和TIGIT.
主要方法:
- 关于免疫检查点和癌症免疫治疗的当前文献的综述.
- 分析T细胞免疫检查点在淋巴瘤中的作用.
- 讨论新的ICI目标和组合疗法的潜力.
主要成果:
- 针对CTLA-4,PD-1和PD-L1的ICI已经显示出临床效用,但有限的持久反应.
- LAG-3,TIM-3和TIGIT正在成为增强抗瘤免疫力的有希望的目标.
- 涉及ICI的组合免疫疗法正在研究中,以提高治疗疗效.
结论:
- 新的免疫检查点代表了克服对当前癌症免疫疗法的耐药性的有希望的途径.
- 针对多个免疫检查点可能会导致淋巴瘤中更强大和持续的抗瘤反应.
- 进一步研究这些检查点的调节和治疗应用对于推进癌症治疗至关重要.
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K

